AB
INMB icon

Amalgamated Bank’s INmune Bio INMB Stock Holding History

Amalgamated Bank’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-641
Closed -$1K – 2209
2025
Q4 		$1K Buy
641
+219
+52% +$391 ﹤0.01% 2947
2025
Q3 		$1K Hold
422
– – ﹤0.01% 2972
2025
Q2 		$1K Hold
422
– – ﹤0.01% 2995
2025
Q1 		$3K Hold
422
– – ﹤0.01% 2785
2024
Q4 		$2K Hold
422
– – ﹤0.01% 2905
2024
Q3 		$2K Hold
422
– – ﹤0.01% 2935
2024
Q2 		$4K Buy
+422
New +$4.16K ﹤0.01% 2856

Other funds holding INMB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Bank's INMB Position: Q1 2026 in Review

Amalgamated Bank sold out of INmune Bio (INMB) in Q1 2026, closing a stake of 641 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in INMB in Q2 2024 and held it in 7 quarters. The position peaked at $4K in Q2 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Amalgamated Bank reported no remaining INmune Bio position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 641 INmune Bio shares in Q1 2026, an estimated $1K.
  • Amalgamated Bank first reported a position in INmune Bio in Q2 2024 and held it in 7 quarters.
  • Amalgamated Bank's INmune Bio position peaked at $4K in Q2 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.